Unity Health Toronto
Toronto, Ontario, Canada
NCT Number: NCT04296630
Using social media for health promotion is an innovative and emerging approach but remains relatively unexplored in cancer screening. Uptake of colorectal cancer (CRC) screening remains low and standard methods of reaching out are expensive with limited impact. The objective of this study is to conduct a cluster randomized controlled trial (RCT) to test the effectiveness of social media messages for CRC screening on screening intention (primary outcome). The results of this trial will be of interest to Ontario Health and are likely to be taken up by other screening programs looking for innovative and novel ways to increase screening participation. The study results will be easily translatable identifying the most compelling CRC screening messages while the approach can easily be translated to other cancer disease sites with screening programs.
Interested in participating?
Request Info55 year–64 year
All sexes
Interventional
Not applicable
Toronto, Ontario, Canada
The investigators will conduct a cluster randomized controlled trial (RCT) in Facebook users (aged 50+) in Ontario. Randomization will be done at the level of the forward sortation area (FSA) - the first three characters of the postal code. All FSAs in Ontario will be randomized to one of six study arms - users assigned to each arm will receive one of the social media messages or no message (control). If users click on the message, a webpage with further information on screening will appear and participants will be asked to indicate intention to get screened for CRC. The primary outcome will be intention to screen and secondary outcomes will include other engagement metrics such as reach, cost-per-click, click-through rates, number of likes, number of impressions, and post comments.
This study will inform the feasibility of using social media for CRC screening and identify the most compelling CRC screening messages for the screen-eligible population.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Social media message promoting colorectal cancer screening
A different social media message promoting colorectal cancer screening
A different social media message promoting colorectal cancer screening
A different social media message promoting colorectal cancer screening.
Tailored social media messages promoting colorectal cancer screening.
Time frame: From date of randomization to end of data collection (1 month)
The proportion of individuals in each arm that click on the ad and confirm their intention to get screened for CRC
Time frame: From date of randomization to end of data collection (1 month)
The average cost per link click calculated as the total amount spent on the ad campaign divided by total number of link clicks
Time frame: From date of randomization to the end of data collection (1 month)
Percentage of times that individuals saw the ads and performed a click
Time frame: At the end of the study period at 1 month
Total number of Facebook likes for each ad
Time frame: At the end of the study period at 1 month
Number of times that each ad was on screen
Time frame: At the end of the study period at 1 month
Number of comments on each ad
Unity Health Toronto
Other
Utilizing Social Media for Colorectal Cancer Screening: an Innovative Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07676383
Breast Cancer, Breast Diseases
View Trial DetailsNCT03174444
Cancer Screening, Colonic Diseases
San Francisco, California, United States
View Trial DetailsNCT07328516
Breast Cancer, Breast Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT06769087
Colonic Diseases, Colorectal Cancer
Seoul, South Korea
View Trial Details